BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12854079)

  • 1. Comparative analysis of type III effector translocation by Yersinia pseudotuberculosis expressing native LcrV or PcrV from Pseudomonas aeruginosa.
    Bröms JE; Sundin C; Francis MS; Forsberg A
    J Infect Dis; 2003 Jul; 188(2):239-49. PubMed ID: 12854079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LcrV is a channel size-determining component of the Yop effector translocon of Yersinia.
    Holmström A; Olsson J; Cherepanov P; Maier E; Nordfelth R; Pettersson J; Benz R; Wolf-Watz H; Forsberg A
    Mol Microbiol; 2001 Feb; 39(3):620-32. PubMed ID: 11169103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The V antigen of Pseudomonas aeruginosa is required for assembly of the functional PopB/PopD translocation pore in host cell membranes.
    Goure J; Pastor A; Faudry E; Chabert J; Dessen A; Attree I
    Infect Immun; 2004 Aug; 72(8):4741-50. PubMed ID: 15271936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Yersinia Yop-effector delivery by translocated YopE.
    Aili M; Isaksson EL; Carlsson SE; Wolf-Watz H; Rosqvist R; Francis MS
    Int J Med Microbiol; 2008 Apr; 298(3-4):183-92. PubMed ID: 17597003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional conservation of the effector protein translocators PopB/YopB and PopD/YopD of Pseudomonas aeruginosa and Yersinia pseudotuberculosis.
    Frithz-Lindsten E; Holmström A; Jacobsson L; Soltani M; Olsson J; Rosqvist R; Forsberg A
    Mol Microbiol; 1998 Sep; 29(5):1155-65. PubMed ID: 9767584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified needle-tip PcrV proteins reveal distinct phenotypes relevant to the control of type III secretion and intoxication by Pseudomonas aeruginosa.
    Sato H; Hunt ML; Weiner JJ; Hansen AT; Frank DW
    PLoS One; 2011 Mar; 6(3):e18356. PubMed ID: 21479247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutant with aberrant extracellular LcrV-YscF interactions fails to form pores and translocate Yop effector proteins but retains the ability to trigger Yop secretion in response to host cell contact.
    Harmon DE; Murphy JL; Davis AJ; Mecsas J
    J Bacteriol; 2013 May; 195(10):2244-54. PubMed ID: 23475976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished LcrV secretion attenuates Yersinia pseudotuberculosis virulence.
    Bröms JE; Francis MS; Forsberg A
    J Bacteriol; 2007 Dec; 189(23):8417-29. PubMed ID: 17873031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type III secretion proteins PcrV and PcrG from Pseudomonas aeruginosa form a 1:1 complex through high affinity interactions.
    Nanao M; Ricard-Blum S; Di Guilmi AM; Lemaire D; Lascoux D; Chabert J; Attree I; Dessen A
    BMC Microbiol; 2003 Oct; 3():21. PubMed ID: 14565848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis.
    Viboud GI; So SS; Ryndak MB; Bliska JB
    Mol Microbiol; 2003 Mar; 47(5):1305-15. PubMed ID: 12603736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes.
    Goure J; Broz P; Attree O; Cornelis GR; Attree I
    J Infect Dis; 2005 Jul; 192(2):218-25. PubMed ID: 15962216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polarisation of type III translocation by Pseudomonas aeruginosa requires PcrG, PcrV and PopN.
    Sundin C; Thelaus J; Bröms JE; Forsberg A
    Microb Pathog; 2004 Dec; 37(6):313-22. PubMed ID: 15619427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation.
    Pettersson J; Holmström A; Hill J; Leary S; Frithz-Lindsten E; von Euler-Matell A; Carlsson E; Titball R; Forsberg A; Wolf-Watz H
    Mol Microbiol; 1999 Jun; 32(5):961-76. PubMed ID: 10361299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissection of homologous translocon operons reveals a distinct role for YopD in type III secretion by Yersinia pseudotuberculosis.
    Bröms JE; Forslund AL; Forsberg Å; Francis MS
    Microbiology (Reading); 2003 Sep; 149(Pt 9):2615-2626. PubMed ID: 12949185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein binding between PcrG-PcrV and PcrH-PopB/PopD encoded by the pcrGVH-popBD operon of the Pseudomonas aeruginosa type III secretion system.
    Allmond LR; Karaca TJ; Nguyen VN; Nguyen T; Wiener-Kronish JP; Sawa T
    Infect Immun; 2003 Apr; 71(4):2230-3. PubMed ID: 12654846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis of the formation of the Ysc-Yop translocation pore in macrophages by Yersinia enterocolitica: role of LcrV, YscF and YopN.
    Marenne MN; Journet L; Mota LJ; Cornelis GR
    Microb Pathog; 2003 Dec; 35(6):243-58. PubMed ID: 14580388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligomerization of PcrV and LcrV, protective antigens of Pseudomonas aeruginosa and Yersinia pestis.
    Gébus C; Faudry E; Bohn YS; Elsen S; Attree I
    J Biol Chem; 2008 Aug; 283(35):23940-9. PubMed ID: 18583342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: evidence of a structural domain necessary for translocation.
    Francis MS; Wolf-Watz H
    Mol Microbiol; 1998 Aug; 29(3):799-813. PubMed ID: 9723919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Amino-Terminal Part of the Needle-Tip Translocator LcrV of
    Ekestubbe S; Bröms JE; Edgren T; Fällman M; Francis MS; Forsberg Å
    Front Cell Infect Microbiol; 2016; 6():175. PubMed ID: 27995096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YopD self-assembly and binding to LcrV facilitate type III secretion activity by Yersinia pseudotuberculosis.
    Costa TR; Edqvist PJ; Bröms JE; Ahlund MK; Forsberg A; Francis MS
    J Biol Chem; 2010 Aug; 285(33):25269-84. PubMed ID: 20525687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.